Aarey Drugs & Pharmaceuticals

Aarey Drugs & Pharmaceuticals

78.53
+2.84
(3.75%)
Market Cap
222.70 Cr
EPS
1.42
PE Ratio
53.55
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
80.95
52 Week Low
31.35
PB Ratio
1.67
Debt to Equity
0.24
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
neutral
Aarey Drugs & Pharmaceuticals Limited's Board of Directors approved unaudited financial results for the quarter ended June 30, 2025. The company reported total income of Rs. 1,037.60 lakhs compared to Rs. 1,288.71 lakhs in the same quarter last year. Profit for the period was Rs. 13.73 lakhs versus Rs. 12.39 lakhs in the corresponding quarter of the previous year. Basic earnings per share stood at Rs. 0.48 compared to Rs. 0.44 in the year-ago period. The company operates in a single segment of manufacturing and trading of drugs and pharmaceuticals. The results were reviewed by auditors Motilal & Associates LLP and certified by Managing Director Mihir R. Ghatalia and Chief Financial Officer Mira M. Ghatalia.
neutral
Aarey Drugs & Pharmaceuticals Submits Revised Annual Financial Results to Correct Share Capital ErrorJul 30, 2025
Aarey Drugs & Pharmaceuticals Limited submitted revised audited financial results for the year ended March 31, 2025, to correct a clerical error in the paid-up share capital disclosure. The company confirmed that no other changes were made to the originally submitted results. The auditors issued an unmodified opinion on the financial results, though they noted that some plant and machinery added to fixed assets is not yet ready for use, so depreciation has not been charged. The auditors also highlighted that some debtor and creditor balances are subject to confirmation as confirmations were not available from all parties.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,586.70
#1 3,80,702.50
33.18
#1 54,729.00
9.71
#1 10,980
-19.84
51.86
5,689.50
1,51,038.30
65.50
9,712.00
18.67
2,191
26.74
36.39
1,499.40
1,21,107.70
22.45
28,409.50
7.12
5,291
9.88
38.89
3,561.00
1,20,520.40
59.72
11,539.40
6.99
1,911
19.91
42.61
1,253.10
1,04,580.10
#1 18.40
33,741.20
16.73
5,725
1.26
46.51
2,482.90
1,02,476.40
54.18
12,744.20
#1 20.90
2,007
-18.14
44.66
975.00
98,107.80
21.07
23,511.00
18.55
4,615
2.60
50.50
1,919.80
87,676.40
23.72
22,909.50
13.74
3,306
#1 51.64
46.16
5,433.00
64,959.70
28.53
13,458.30
3.70
2,216
21.39
61.31
1,090.00
63,307.40
18.84
32,345.60
9.43
3,484
-10.24
53.78
Forecast
Actual
Growth Rate
Revenue Growth
20.17 %
Net Income Growth
-14.89 %
Cash Flow Change
444.48 %
ROE
-17.56 %
ROCE
7.03 %
EBITDA Margin (Avg.)
-7.39 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
216
249
399
353
359
307
355
495
422
403
484
459
Expenses
212
245
386
342
347
297
344
481
411
391
471
446
EBITDA
4
4
13
11
12
10
12
14
11
11
13
13
Operating Profit %
1 %
0 %
2 %
2 %
2 %
1 %
1 %
2 %
2 %
1 %
1 %
1 %
Depreciation
1
1
1
1
1
1
1
2
2
2
2
3
Interest
2
2
4
2
2
2
2
2
3
4
5
3
Profit Before Tax
1
2
8
8
9
7
8
10
6
5
6
7
Tax
0
1
3
2
2
1
2
4
2
1
2
2
Net Profit
1
1
6
6
7
6
7
7
4
5
4
4
EPS in ₹
0.65
0.77
3.03
2.64
2.80
2.48
2.79
2.72
1.49
1.84
1.42
1.50

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
115
125
143
170
146
194
233
245
291
303
291
Fixed Assets
6
8
12
12
12
12
14
15
14
13
16
Current Assets
109
117
130
157
133
181
218
219
271
283
266
Capital Work in Progress
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
1
2
Other Assets
109
117
130
157
133
181
218
230
277
289
272
Total Liabilities
115
125
143
170
146
194
233
245
291
303
291
Current Liabilities
80
88
92
88
58
100
131
127
168
167
149
Non Current Liabilities
0
0
2
1
2
2
3
5
6
4
3
Total Equity
35
37
49
80
87
92
99
114
117
133
139
Reserve & Surplus
19
20
30
55
61
67
73
86
87
100
105
Share Capital
17
17
18
23
23
23
23
25
25
28
29

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-1
2
-1
2
-3
0
0
-1
1
1
-0
Investing Activities
-2
-3
-5
-1
-1
-1
-3
-3
0
-2
-6
Operating Activities
3
6
1
-20
1
3
6
1
-1
-3
10
Financing Activities
-2
-2
4
23
-3
-2
-3
2
1
6
-5

Share Holding

% Holding
Mar 2021
Jun 2021
Jul 2021
Sept 2021
Nov 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
49.38 %
49.38 %
49.38 %
49.38 %
48.05 %
48.05 %
48.06 %
50.03 %
50.03 %
50.03 %
50.04 %
50.04 %
50.04 %
50.04 %
45.28 %
45.28 %
45.44 %
44.80 %
44.80 %
44.80 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
3.40 %
3.40 %
2.75 %
2.34 %
2.34 %
1.97 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
37.15 %
40.16 %
40.14 %
40.44 %
42.40 %
42.23 %
43.30 %
42.48 %
42.25 %
42.41 %
42.24 %
42.15 %
40.61 %
41.14 %
47.14 %
44.51 %
47.56 %
44.87 %
45.79 %
46.60 %
Others
13.46 %
10.46 %
10.47 %
10.18 %
9.54 %
9.72 %
8.63 %
7.48 %
7.71 %
7.55 %
7.72 %
7.81 %
9.35 %
8.82 %
4.18 %
6.82 %
4.25 %
7.99 %
7.07 %
6.63 %
No of Share Holders
10,688
12,828
13,731
13,158
13,150
13,658
17,565
17,777
17,649
17,785
17,699
17,538
16,086
15,269
16,821
16,179
16,676
16,288
16,257
15,796

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
29 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Sept 2025 70.32 78.72
29 Dec 2023 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
29 Dec 2023 44.60 49.15
29 Dec 2023 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Dec 2023 44.60 49.15
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 71.53 70.94
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 64.76 58.47
14 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Feb 2025 47.74 46.20
30 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 May 2025 53.29 53.80
13 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Aug 2025 68.48 65.79

Announcements

Corrigendum To The Integrated Annual Report For FY 2024-253 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 12, 2025
Reg. 34 (1) Annual Report.Sep 06, 2025
Notice Of 35Th Annual General Meeting Of The Company For The Financial Year 2024-25Sep 06, 2025
Intimation Of Book ClosureSep 06, 2025
Revised Outcome Of Board Meeting Held On 03Rd September 2025Sep 04, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 03, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 03" September 2025Sep 03, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 18, 2025
Unaudited Financial Results For The Quarter Ended 30Th June 2025 Along With The Limited Review Report MD/CFO Certification.Aug 13, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E 13Th August 2025Aug 13, 2025
Board Meeting Intimation for Intimation Of Board MeetingAug 07, 2025
Revised Filing Of Audited Financial Results For The Year Ended 31St March 2025Jul 30, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2025
Closure of Trading WindowJun 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 03, 2025
Reg. 33 - Audited Financial Results For The Quarter & Financial Year Ended 31St March 2025May 30, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Friday I.E 30Th May 2025May 30, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
Announcement under Regulation 30 (LODR)-AllotmentMay 23, 2025
Board Meeting Intimation for Board Meeting IntimationMay 22, 2025
Reg 30 Of SEBI LODRMay 08, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 11, 2025
Clarification On Price MovementApr 09, 2025
Clarification sought from Aarey Drugs & Pharmaceuticals LtdApr 07, 2025
Closure of Trading WindowMar 26, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMar 06, 2025
Appointment of Company Secretary and Compliance OfficerMar 06, 2025
Board Meeting Outcome for Intimation Regarding Appointment Of Company Secretary And Compliance Officer Of The Company Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 06, 2025
Integrated Filing (Financial)Feb 17, 2025
Unaudited Financial Result For December 2024Feb 14, 2025
Board Meeting Outcome for OutcomeFeb 14, 2025
Board Meeting Intimation for Quarterly Financial ResultFeb 06, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2025
Announcement under Regulation 30 (LODR)-Change in RTAJan 08, 2025
Announcement under Regulation 30 (LODR)-CessationJan 02, 2025
Board Meeting Outcome for OutcomeJan 02, 2025
Shareholder Meeting / Postal Ballot-Outcome of EGMJan 02, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 30, 2024
CorrigendumDec 27, 2024
Reg 30 Notice Of General MeetingDec 06, 2024
EGM NoticeDec 06, 2024
Announcement under Regulation 30 (LODR)-Meeting UpdatesDec 04, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementDec 04, 2024
Announcement under Regulation 30 (LODR)-Preferential IssueDec 04, 2024
Board Meeting Outcome for OutcomeDec 04, 2024
Closure of Trading WindowNov 29, 2024
Board Meeting Intimation for Raising Funds By Way Of Preferential Issue Of Shares Or Warrants Or Any Other MethodNov 29, 2024
Board Meeting Outcome for OutcomeNov 29, 2024
Closure of Trading WindowNov 26, 2024

Technical Indicators

RSI(14)
Neutral
66.10
ATR(14)
Volatile
3.61
STOCH(9,6)
Neutral
77.96
STOCH RSI(14)
Neutral
43.31
MACD(12,26)
Bullish
0.46
ADX(14)
Weak Trend
22.02
UO(9)
Bearish
64.21
ROC(12)
Uptrend And Accelerating
8.03
WillR(14)
Neutral
-20.25